DEKA Laser and New York’s Romeo & Juliette: A Global Partnership for Advanced Epilation on Fifth Avenue
DEKA Laser, global leader in medical laser technologies, proudly announces its new and prestigious partnership with Romeo & Juliette Hair Removal, the renowned center specialized in permanent hair removal located on world-famous Fifth Avenue in New York City. Thanks to this exclusive collaboration, Romeo & Juliette will become another global reference center for DEKA training on laser hair removal, with particular attention to the Again PRO Series line of equipment, and will host the innovative DEKA Epil Academy, an academy dedicated to the training and sharing of advanced hair removal treatment protocols.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241204652458/en/
Located on one of the most elegant and most renowned avenues in the world, Romeo & Juliette Hair Removal is considered true excellence in the aesthetic and medical realm, and is frequented by celebrities, top models and prominent sports personalities. This new international training center will become the reference point for physicians and specialists from all over the world who wish to train on the most innovative and effective laser hair removal protocols, in particular for the treatment of all phototypes.
“The collaboration with Romeo & Juliette represents a significant achievement for DEKA”, says Paolo Salvadeo, DEKA Laser’s CEO. “This partnership allows us to take our quality and innovation standards to one of the most iconic and prestigious locations in the world, making the training experience unique in its type. I am proud to be able to give life to this project, which will contribute to the growth and diffusion of the Again PRO technology and our advanced hair removal protocols.
Also Chris Karavolas, Director of the Romeo & Juliette Center, expresses his enthusiasm for this new phase: “We are thrilled to cooperate with DEKA, a subsidiary of the El.En. Group, an absolute reference company in the world of laser technology. This synergy will allow us to offer cutting-edge treatments to our clients, constantly optimizing the protocols for every skin type. For us working side by side with DEKA and El.En. Group represents a unique growth and development opportunity”.
Chris Karavolas, with over twenty years of experience in the hair removal field, will work closely with the DEKA team to perfect the treatment protocols for every skin type, contributing to positioning Romeo & Juliette and DEKA Laser as global leaders in the sector.
The DEKA Epil Academy will position itself as a center of excellence in the hair removal training, attracting professionals the world over toward the famous Fifth Avenue, a meeting place of innovation, beauty and technology.
https://dekalaser.com/products/again-pro/
https://www.romeojuliettelaserhairremoval.com/
Information on DEKA
DEKA is a subsidiary of the EL.EN. multinational Group which has been the leader in the laser work for 40 years.
This Italian company, headquartered in Florence, has its roots in a culture whose dominant characteristic is excellence of thought. Thanks to its priceless cultural heritage and its unique historical background, DEKA enshrines a promise of universal value in its vision: Transforming each scientific discovery into a solid benefit for physicians and patients and translate each technological innovation into ongoing improvement in its product and services range to ameliorate the quality of people’s lives.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241204652458/en/
Contacts
DEKA M.E.L.A. Press Office
Davide Zotta
+39 342 6204053 – d.zotta@deka.it
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Transition Industries and Veolia Partner to Redefine Industrial Water Use at the Pacifico Mexinol Project in Mexico13.1.2025 10:24:00 EET | Press release
Transition Industries LLC, a developer of world-scale, net-zero carbon emissions methanol and hydrogen projects, and Veolia Water Technologies & Solutions, world leader in water technology, have signed an agreement to explore the provision of advanced industrial water technology for the Pacifico Mexinol project in Sinaloa, Mexico. Expected to initiate operations in 2028, Pacifico Mexinol is poised to be the world’s largest standalone ultra-low carbon chemical production facility in the world, with an output of 6,145 metric tons of methanol (MT) per day. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250112655528/en/ The memorandum of understanding (MOU) outlines the collaboration between Transition Industries and Veolia to develop a purpose-driven water strategy for the Pacifico Mexinol project. Designed with Ahome Municipality’s Drinking Water and Sewage Board (JAPAMA), this strategy would make the Pacifico Mexinol site one
Egle Therapeutics Strengthens its Executive Leadership Team With the Appointment of Christophe Quéva, Ph.D., as Chief Executive Officer13.1.2025 10:00:00 EET | Press release
Egle Therapeutics, a clinical-stage biotechnology company advancing the next generation of regulatory T cell (Treg)-focused therapies for oncology and autoimmune diseases, today announced the appointment of experienced biotechnology industry executive, Christophe Quéva, Ph.D., as Chief Executive Officer (CEO). With over 20 years of experience in the biotechnology industry, Dr. Quéva brings a wealth of expertise as Egle transitions into the clinic its two lead drug candidates, EGL-001 and EGL-003. “I am thrilled to join Egle Therapeutics and collaborate with a team renowned for its deep scientific expertise in regulatory T cells and its strong track record in developing innovative drug candidates for immunology and oncology,” said Christophe Quéva, Ph.D. “Egle is uniquely positioned to demonstrate the therapeutic potential of harnessing regulatory T cells for treating both cancer and autoimmune diseases.” “As we transition from a company with preclinical assets to a fully-fledged clinic
Avanzanite Bioscience Announces Appointment of Chief Technical Officer to Accelerate European Expansion and Drive Growth13.1.2025 08:00:00 EET | Press release
Avanzanite Bioscience B.V., a leading commercial-stage specialty pharmaceutical company committed to bringing ground-breaking medicines for rare diseases to market, announced today the appointment of Jason Cameron as Chief Technical Officer (CTO). This move marks a significant step in Avanzanite’s mission to accelerate growth, expand its presence in Europe, and advance the company’s next phase of international partnerships and product launches. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250112229499/en/ Jason Cameron, Chief Technical Officer, Avanzanite Bioscience (Photo: Business Wire) As CTO, Cameron will initially focus on the strategic expansion of Avanzanite’s footprint into 26 European countries, driving revenue growth for the current portfolio while also preparing for key new partnerships expected to materialize in 2025. With over 25 years of experience in pharmaceutical operations, Mr. Cameron brings unparalleled
Dubai Culture Launches ‘Creative Dubai – Navigating Tomorrow’s Creative Landscape’ Report13.1.2025 08:00:00 EET | Press release
Dubai Culture and Arts Authority (Dubai Culture) has launched the ‘Creative Dubai: Navigating Tomorrow’s Creative Landscape’ report developed in collaboration with DinarStandard, a privately owned growth strategy research and advisory firm empowering organisations for responsible global impact. The report highlights Dubai’s achievements in the cultural and creative industries, the key factors contributing to the city’s cultural vision, and significant data tracking the sector’s transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250112169940/en/ Key Highlights of Creative Economy Figures and FDI in Dubai’s Cultural and Creative Industries (Graphic: AETOSWire) The report provides a comprehensive overview of the creative sector, which serves as a significant global economic force, representing 6.1% of the global economy with a total value of US$4.3 trillion. The report also shows that the UAE has the largest creativ
PQ Completes Acquisition of Sibelco's Specialty Silicate Business in Sweden13.1.2025 07:00:00 EET | Press release
PQ (www.pqcorp.com), a leading global producer of silicates, silicas and derivative products, announced that it has completed the acquisition of the specialty silicate business of the Sibelco Group currently operated in the Lödöse plant in Sweden. “PQ is pleased to complete this transaction with Sibelco and we are excited to begin offering our products and service to new customers in the region,” said Al Beninati, CEO of PQ. “Our robust European network and expertise in specialty silicates will enable our new customers to achieve growth across the Nordics.” About PQ With headquarters in Malvern, Pennsylvania PQ is a leading global provider of silicates, silicas and derivative products. PQ’s products are found in a wide variety of industries and many aspects of everyday life, from decorative paints to green cement, from clean drinking water to green tires and from toothpaste to aiding in the production of biofuels and beer. Supported by 1,500 employees across 30 facilities in 13 countri
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom